CNSP - Company ID 0001729427
CNS Pharmaceuticals, Inc. trades as CNSP. This page tracks CNS Pharmaceuticals, Inc. through 379 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| EFFECT | - | 2026-05-26 |
| 424B3 | - | 2026-05-26 |
| Insider trade | 4 | 2026-05-20 |
| D | - | 2026-05-19 |
| Securities registration | S-3 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-04 |
The largest companies sharing CNS Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year CNS Pharmaceuticals, Inc. reported a net loss of $15.85M.